In the brain, the expression of the pleiotropic cy tokine interleukin-6 (IL-6) is enhanced in various chronic or acute central nervous system disorders. However, the signifi cance of IL-6 production in such neuropathologic states re mains controversial. The present study investigated the role of IL-6 after cerebral ischemia. First, the authors showed that focal cerebral ischemia in rats early up-regulated the expression of IL-6 mRNA, without affecting the transcription of its recep tors (IL-6Ra and gpI30). Similarly, the striatal injection of N-methyl-D-aspartate (NMDA) in rats, a paradigm of excito toxic injury, activated the expression of IL-6 mRNA. The in volvement of glutamatergic receptor activation was further in vestigated by incubating cortical neurons with NMDA or a -amino-3-hydroxy -5-meth y 1-4-isoxazolepropionate (AMP A). NMDA and ionomycin (a calcium ionophore) up-regulated IL-6 mRNA, suggesting that neurons may produce IL-6 in 956 response to the calcium influx mediated through NMDA re ceptors. The potential role of IL-6 during ischemic/excitotoxic insults was then studied by testing the effect of IL-6 against apoptotic or excitotoxic challenges in cortical cultures. IL-6 did not prevent serum deprivation-or staurosporine-induced apop totic neuronal death, or AMPAlkainate-mediated excitotoxic ity. However, in both mixed and pure neuronal cultures, IL-6 dose-dependently protected neurons against NMDA toxicity.
Increasing evidence suggests that, in addition to apop totic and excitotoxic pathways (Choi, 1996) , the immune response to tissue damage may also significantly influ ence the neuronal outcome after ischemic brain injury, For example, the striatal injection of the proinflamma tory cytokine interleukin-l � (IL-l �) worsens ischemic brain lesions (Stroemer and Rothwell, 1998) , whereas the intracerebral injection of the immunosuppresive cy tokine transforming growth factor-� (TGF-�) is neuro protective in experimental cerebral ischemia (Prehn et aI., 1993) , Although the involvement of immunel inflammatory cytokines, such as IL-1�, TNF-a or TGF �, in the ischemic neuronal death has been extensively studied (Loddick et aI., 1997; Feuerstein et aI., 1998; DeGraba, 1998; Buisson et aI., 1998) , the role of IL-6 remains to be elucidated, First identified as a B-cell stimulating factor (Hirano et aI., 1986) , IL-6 belongs to a subfamily of related he matopoietic cytokines, including leukemia inhibitory factor, ciliary neurotrophic factor, oncostatin-M, cardio trophin-1 and IL-11, To exert its biological effects, IL-6 first binds to either the soluble or the membrane associated receptor IL-6Ra. This complex then recruits the signal transducer gp 130, a transmembrane glycopro tein common to the IL-6 related cytokines, as an obliga tory component for signal transduction. The subsequent dimerization of gp130 activates the Jak/STAT and MAPK pathways, allowing the transcriptional modula tion of target genes (Akira, 1997; Heinrich et aI., 1998; Hirano, 1998) .
The expression of IL-6 in the brain increases in nu merous neurological disorders, such as Alzheimer's dis ease, Parkinson's disease, meningitis, trauma, and stroke (Gruol and Nelson, 1997; Benveniste, 1998) . IL-6 has been reported to be up-regulated after focal permanent ischemia in rats (Wang et aI., 1995) and transient global ischemia in gerbils (Saito et aI., 1996) . However, con flicting data have been reported with regard to the po tential role of IL-6 production during both acute and chronic insults to the brain. The intracerebral injection of IL-6 in rats reduces the infarcted volume after focal per manent cerebral ischemia (Loddick et aI., 1998) and pro tects striatal cholinergic neurons against N-methyl-D aspartate (NMDA)-induced toxicity (Tou1mond et aI., 1992) . However, transgenic mice that overexpress IL-6 in astrocytes exhibit learning disabilities and prominent neurodegeneration (Campbell, 1998) . In vitro, IL-6 has been shown to exert a neurotrophic activity in forebrain neurons (Kushima et aI., 1992) and to protect PC12 cells against an hypoxia-reoxygenation paradigm (Maeda et aI., 1994) . While some data indicate that IL-6 reduces the glutamate-induced neuronal death in hippocampal cul tures (Yamada and Hatanaka, 1994) , other authors have evidenced either no benefit of IL-6 against excitotoxicity in cortical neurons (Toulmond et aI., 1992) or an en hancement of NMDA toxicity in cerebellar granule neu rons chronically exposed to IL-6 (Qiu et aI., 1998) .
The aim of the present investigation was to assess the possible involvement of IL-6 in cerebral ischemia. First, the expression of IL-6 and its receptors after permanent or transient focal cerebral ischemia in rats was examined. Then, the expression of IL-6 and its signalling receptors after the exposure of brain tissue to NMDA both in vivo and in vitro was investigated. Finally, the authors char acterized the effect of IL-6 against the neuronal death induced by either excitotoxic or apoptotic paradigms in murine cortical cultures.
MATERIALS AND METHODS
Polymerase chain reaction and reverse transcriptase system kits were purchased from Promega (Charbonnieres, France).
Dulbecco's Eagle's minimal essential medium, Poly-D-Iysine, cytosine f3-D-arabinoside (AraC), horse serum, fetal calf se rum, Tween 20, ionomycin (A23187), staurosporine, Extravi din, MAP2 and glial fibrillary acidic protein (GFAP) antibodies and the synthetic IL-6 competitive inhibitor were obtained from Sigma Chemical Co. (L'Isle D' Abeau, France). NMDA, a-amino-3-hydroxy -5-methy 1-4-isoxazolepropionate (AMP A), 6-cyano-7 -nitroquinoxaline-2,3-dione, kainate and (+)5methyl-IO, II-dihydro-5H-dibenzo(a,d)cyclohepten-5, 10-imine maleate (MK-80l) were from Tocris (Bristol, U.K.). Laminin was from Life Technologies (Cergy Pontoise, France). Mouse recombinant IL-6 (specific activity: 105 U/f.Lg) was purchased from R&D Systems (Oxford, U.K.). Antibodies raised against IL-6Ra and gpl30 were from Santa Cruz (Heidelberg, Germany).
In vivo procedures
All experiments were performed on male Sprague-Dawley rats weighing 280 to 320g (CERJ, France). Anesthesia, induced by halothane 4% and maintained at 1-1.5%, was administrated through a vaporizer in a gas mixture of 30% O2:70% N20.
Middle cerebral artery occlusion. All of the rats used for ischemia procedures were intubated and a femoral artery was cannulated for continuous arterial pressure monitoring and gas analysis. Body temperature was maintained at 37.5°C ± 0.2°C with a heating pad. Focal cerebral ischemia was induced by intraluminal middle cerebral artery occlusion (MCAO) (Long a et ai, 1989) . Briefly, a midline neck incision was made and the right common carotid artery was exposed. After coagulation of its branches, the external carotid artery was severed distally. A nylon thread (0.18mm in diameter) having a distal cylinder (3mm long and 0.38mm in diameter) of thermofusible glue (3M:3764; Radiospares composantes, Paris, France) was in serted in the lumen of the external carotid artery and pushed into the internal carotid artery up to the origin of MCA. In the case of transient focal ischemia, the nylon thread was removed and cut 90 minutes later, so as to restore blood flow in the MCA. Rats were killed 3, 6, 24 and n hours after MCAO, and cortices were isolated for reverse transcription polymerase chain reaction (RT-PCR) analysis.
Excitotoxic lesions. Rats received a unilateral injection (3 f.LL) into the left striatum (coordinates 0.2 mm posterior, 3 mm lateral, 5.5 mm ventral to the bregma; Paxinos and Watson, 1986) with either vehicle (phosphate-buffered saline [PBS], pH 7.4) or NMDA (75 nmol in PBS, pH 7.4). Five minutes after insertion of the needle, the solution was injected over the next 6 minutes using a Hamilton syringe pump (Carnegie, Stock holm, Sweden) at a rate of 0.5 f.LLlmin. The needle was re moved 5 minutes later. Rats were killed after I, 6 and 24 hours and the striata were collected for RT-PCR analysis.
Cell culture. Mixed cortical neuron and glial cell cultures were prepared from fetal OFI mice at 15 to 16 days gestation (Rose et aI., 1993) . After removing the meninges, isolated ce rebral cortices were mechanically dissociated in media stock (MS, minimal essential medium with 25 mmollL glucose). The cell suspension was adjusted with MS supplemented with 2 mmollL glutamine, 5% fetal calf serum, and 5% horse serum, before plating on a preformed confluent layer of astrocytes. The latter (containing no neurons) was derived from 1-to 3-day-old mice following the same procedure, with the exception that the culture medium was MS supplemented with 2 mmollL gluta mine, 10% fetal calf serum and 10% horse serum.
Near pure neuronal cultures containing <5% glial cells were obtained as described above, but were plated on a poly-D lysine and laminin layer.
All cultures were kept at 37°C in a humidified 5% CO2 atmosphere. Non-neuronal cells proliferation was halted by adding 10 f.LmollL AraC after 3 days in vitro for near pure neuronal cultures and 7 days in vitro for mixed cultures. Three days before the experiments, culture media were exchanged for MS +10 f.LmollL glycine.
Semiquantitative reverse transcription polymerase chain reaction
Total RNAs were isolated from rats cerebral cortices and striata or murine cell cultures through the use of the RNaxel kit (Eurobio, Les Ulis, France), or RNeasy kit (Qiagen. Courta boeuf, France), respectively. One f.Lg of total RNAs was reverse transcribed into cDNA using poly(dT) oligonucleotides that allow a specific targeting of poly(A +)mRNA. For semiquanti tative experiments with f3-actin as a housekeeping gene, an aliquot of the cDNA library (I f.LL) was amplified by PCR with specific sets of oligonucleotides (Table I ). Amplification con ditions using a Thermolyne thermocycler (Amplitron II; Barn stead, Dubuque, lA, U.S.A.) were the following: 95°C-30 sec onds, 55°C-30 seconds, and noc-I minute for f3-actin, IL-6 and gp 130; and 95°C-30 seconds, 58°C-30 seconds, and 
SDS·PAGE and Western Blotting
Murine cultured cortical neurons and astrocytes were lysed in Tris-NaCI-Triton buffer and centrifuged for 5 minutes (2500 g) to obtain whole cell extracts. Then, sodium dodecyl sulfate polyacrylamide gel electrophoresis was performed before im mobilization on a polyvinyl difluoride membrane. Western blotting were exposed for I hour to the primary antibodies (I: 1500), I hour to the appropriate secondary biotin-conjugated antibody (I: 1000), and for I hour to Extravidin (I :2000) before revelation using a chemiluminescence kit (NEN, Paris, France).
In vitro toxicity experiments
Excitotoxicity. Slowly triggered excitotoxicity was induced at 37°C in mixed neuron-glia or pure neuronal cortical cultures (DIV 14) by a 24-hour exposure to 12.5 f,LmollL NMDA, 10 f,LmollL AMP A or 50 f,LmollL kainate in MS supplemented with glycine (Choi, 1992) . MK-80l (10 f,LmollL) was always added concurrently with AMPA or kainate to block secondary activation of NMDA receptors. Excitotoxins were applied alone or concurrently with mouse recombinant IL-6 (mrIL-6).
Neuronal death was estimated by examining the cultures under phase-contrast microscopy and quantitated by measuring lactate dehydrogenase (LDH) release from damaged cells into the bathing medium one day after the onset of exposure to the appropriate excitotoxin (Koh and Choi, 1987) . The LDH level corresponding to complete neuronal death (without glial death) was determined in parallel dishes exposed to 200 f,Lmol/L NMDA. Background LDH levels were determined in sister cultures subjected to sham wash and subtracted from experi mental values to yield the signal specific for experimentally induced injury.
Apoptosis. Serum deprivation was initiated by transferring near pure neuronal cultures (DIV 7) for 24 hours into growth medium lacking serum (Martin et aI., 1988) in the presence or absence of mrIL-6. Secondary NMDA receptor activation was blocked by the addition of MK-80l to the bathing medium.
Neuronal death was assessed by phase-contrast cell counting after staining with 0.4% trypan blue dye. The percentage of neuronal death was estimated as the ratio of trypan blue posi tive neurons after serum deprivation to the total neurons labeled with the same dye after paraformaldehyde permeation.
Staurosporine exposure was performed at 37°C for 24 hours by transferring mixed cortical cell cultures in MS supplemented with glycine, containing 200 nmollL of staurosporine (Koh et aI., 1995) with or without mrIL-6. MK-801 was added concur rently to staurosporine to block secondary NMDA receptor activation. Neuronal death was assessed by the measurement of LDH release.
Statistical analysis
Results are expressed as mean ± SD. Statistical analysis consisted in one-way variance analysis, followed by Bonfer ronni-Dunn's test.
RESULTS

Specificity of the PCR products
Oligonucleotide probes were designed from the pub lished cDNA sequence of IL-6 (Chiu et ai., 1988) , IL-6Ra (Sugita et ai., 1990) and gp 130 (Saito et ai., 1992) . Each set of oligonucleotides used for semiquantitative RT-PCR studies gave the PCR product of the expected size (638 bps for IL-6, 320 bps for IL-6Ra and 405 bps for gp130), as illustrated in Fig. 1 . The specificity of the PCR products was confirmed by restriction digest con trols. IL-6 and IL-6Ra PCR products were digested us ing Alul endonuclease, whereas the gp130 PCR product was submitted to EcoRI digestion. Fig. I shows that restriction enzymes generated the expected fragments of 365, 166, and 107 bps for IL-6 ( Fig. 1A) ; 155 and 111 bps for IL-6Ra (two expected fragments of 46 and 8 bps were not visualized because of their small size) (Fig.  IB) ; 215 and 190 bps for gp130 ( Fig. IC) .
As predicted by the high degree of homology between the rat and the mouse cDNA sequences encoding for IL-6 and its receptors, similar results were obtained with cDNAs derived from rat cerebral cortex (data not shown). ucts. Total RNAs were extracted from murine cerebral cortex and reverse transcribed using a poly(dT) primer. PCR amplifica tion was then performed using specific sets of primers (Table 1) . Agarose gel electrophoresis of the IL-6 PCR product digested or not digested by Alul (A), the IL-6Ra PCR product digested or not di gested by Alul (8), and the gp130 PCR product digested or not digested by EcoRI (C). NO, not digested.
Total RNAs from ipsi-and contra-lateral cortices were harvested at the indicated times after permanent or tran sient MCAO. RNA samples (l J..l g) were then reverse transcribed with poly-dT oligonucleotides. An aliquot of the cDNA libraries (l J..l l) was amplified by peR with specific sets of oligonucleotides for [3-actin, IL-6, IL-6Ra or gp130. The expression pattern of IL-6 and its related receptors in a model of permanent cerebral isch emia was then studied. As shown in Fig. 2A , all PCR reactions showed the same level of the chosen house keeping gene ([3-actin) . The IL-6 cDNA product was not detected in ipsi-and contra-lateral cortices obtained 6 hours after the intervention in sham rats. However, in the injured cortex the expression of IL-6 mRNA enhanced at 3 hours, peaked at 24 hours, and returned to baseline levels after 3 days. In contrast to IL-6, the expression of IL-6Ra and gp130 receptors mRNAs remained un changed. The expression of IL-6 mRNA in a model of 90 minutes transient cerebral ischemia displayed a pattern slightly delayed when compared to the model of perma nent cerebral ischemia (Fig. 2B) . After both transient and permanent focal ischemia, a transient increase in IL-6 mRNA levels was observed in the contralateral cortex. As previously suggested, this increase could result from the physical deformation of the contralateral hemisphere induced by the swelling in the injured ischemic side (Lad dick et a!., 1998). Overexpression of IL-6 mRNA after the intrastriatal injection of NMDA Histologic analysis revealed that, whereas the striatal injection of vehicle (PBS) alone did not induce any sig nificant lesion, rats injected with NMDA (75 nmol/L in PBS) exhibited a lesion volume of 27.0 ± 2.5 mm 3 (mean ± SD, n = 8) (Ruocco et aL, 1999) .
Total RNAs (l I-lg) harvested from the control and injected rat striata were submitted to reverse transcrip tion using poly-dT oligonucleotides and peR was per formed for IL-6, IL-6Ra, gp130, and l3-actin mRNAs, as described above. All peR reactions showed the same level of expression of the chosen housekeeping gene (13actin) ( Fig. 3) . Figure 3 shows that, in contrast to the transcription of both IL-6 related receptors (IL-6Ra and gp130), the ex pression of IL-6 mRNA after striatal injection of NMDA displayed a marked overexpression after 6 hours, that returned to control levels after 24 hours. As observed after focal ischemia (Fig. 2) , a minor increase in IL-6 mRNA was detected in the contralateral striatum at 1 and 6 hours. After 3 hours, the injection of the vehicule (PBS) into the striatum induced only minor modifica tions in IL-6 mRNA levels. also induce an increase of this cytokine. By using semi quantitative RT -peR, the authors studied the transcrip tional expression of IL-6 in cultured neurons after expo sure to AMPA or NMDA. Near pure neuronal cultures (DIV 14), obtained from the cortex of mice were exposed for a short period (less than 3 hours) to high concentra tions (50 I-lmollL) of glutamatergic agonists (the AMPA exposure was performed in the presence of 10 I-lmollL MK-801 to prevent secondary NMDA receptor activa tion), These applications induced an acute swelling of neuronal bodies but did not alter the membrane per meability, as estimated by the LDH release into the bath ing medium (data not shown). As shown in Fig, 4A , after NMDA exposure. However, NMDA treatment en hanced the transcription of IL-6 in a time-dependent manner. This neuronal overexpression of IL-6 was spe cifically induced by NMDA, because it was completely blocked in the presence of the NMDA antagonist, MK-801 ( Fig. 4B) . After 3 hours, exposure to MK-80 l (lOf,LmolfL) had no effect on IL-6 transcription as com- pared to control cultures (data not shown). The authors thus postulated that this induction of IL-6 mRNA could result from the calcium influx mediated through the ac tivation of NMDA receptors. The authors tested this hy pothesis by exposing near pure neuronal cultures to the calcium ionophore, ionomycin (5j-LmollL in the presence of lOj-LmollL MK-801 to prevent excessive NMDA re ceptor activation). The addition of ionomycin induced an up-regulation of IL-6 mRNA over the same interval of time as seen after the application of NMDA (Fig. 5) .
Expression of IL-6 related receptors in cultured cortical neurons and astrocytes
The cellular expression of IL-6 related receptors in murine cortical cultures was determined at both the mRNA and protein levels. RT-PCR studies revealed that both cultured cortical neurons (DIV 14) and astrocytes exhibited mRNAs for IL-6Ra and gp130 (Fig. 6A ). Western blotting analysis performed with an antibody raised against IL-6Ra (80 kDa) or gp130 (130 kDa) re vealed the presence of a single band at the expected molecular weight (Fig. 6B) ; thus demonstrating that neu rons and astrocytes in culture express both IL-6 related receptors, as described in the rodent adult brain (Schobitz et aI., 1993; Gadient and Otten, 1994; Watanabe et aI., 1996) . The expression of IL-6Ra and gp 130 in cortical 
astrocytes and neurons was confirmed by immunocyto chemistry (Fig. 6C ).
IL-6 is neuroprotective against NMDA-induced neuronal death
To test whether IL-6 might alter neuronal outcome after an ischemic insult, the authors determined the ef fects of mouse recombinant IL-6 (mrIL-6) on murine cortical cell cultures exposed to apoptotic or necrotic paradigms.
To induce apoptosis, pure cortical neuronal cultures were transferred after 7 days in vitro (DIV 7) to a serum deficient medium supplemented with MK-801 (Martin et aI., 1988) , that provokes the degeneration of approxi mately 50% of neurons over 24 hours. This treatment resulted in three features typical of apoptosis: (1) a gradual shrinkage of the cell body was exhibited by neu rons; (2) death was blocked by the addition of cyclohex imide (Chx), a protein synthesis inhibitor; and (3) death was accompanied by the appearance of DNA fragmen tation (data not shown). The addition of mrIL-6 to the bathing medium (50 ng/ml) failed to modify the extent of neuronal degeneration (Fig. 7) (n = 10). This lack of effect was not due to the absence of IL-6 receptors in 7-day-old cultured neurons, because both IL-6Ra and ·significantly different from NMOA alone by ANOVA, followed by Bonferronni-Ounn's test (P < 0.0001).
gp130 (mRNAs and proteins) are expressed in these cul tures (data not shown).
In addition, neuronal apoptosis was also induced by exposing mixed neuron-glia cultures (DIV 14) to stau rosporine, a nonspecific protein kinase inhibitor (Koh et aI., 1995) . Although cycloheximide blocked neuronal death, the addition of mrIL-6 (50 ng/mL) was without effect (Fig. 7) (n = 14) .
Thereafter, the authors determined the influence of IL-6 on excitotoxic necrosis, a process morphologically distinct from apoptosis and characterized by a prominent and early cell swelling. Necrosis was induced over 24 hours by the following glutamatergic agonists: NMDA (l2.5/LmoIlL), AMPA (lO/LmoI/L) and kainate (50/Lmoll L) (Choi, 1992) . The exposure of mixed cortical neuron glia cultures (DIV 14) to these agonists produced an acute swelling of neuronal bodies, followed 24 hours later by widespread neuronal degeneration, whereas the glia remained intact. Although mrIL-6 (from 5 to 50 ng/mL) was found ineffective against AMPA-or kain ate-induced toxicity (Fig. 8 ) Cn = 12), it significantly reduced NMDA-induced necrotic neuronal death in mixed neuron-glia cultures, as illustrated by the large restoration of MAP-2 immunostaining organization (Fig.  9A) . The quantification of the neuroprotective effect of IL-6 revealed that it was dose-dependent ( Fig. 9B ) (n = 13; P < 0.001). The potential role of astrocytes in the neuroprotective activity of IL-6 was investigated by ap plying NMDA C12.5/Lmol/L) for 24 hours in near pure neuronal cultures (DIV 14) . In these cultures, mrIL-6 (50 ng/mL) was able to display a neuroprotective activity against NMDA-induced necrotic death ( Fig. 9C ) (n = 16; p < 0.0001). To characterize the effect of mrIL-6 on NMDA-induced necrotic neuronal death, the authors tested a polypeptide fragment corresponding to amino acids 88 to 121 of human IL-6 (IL-6 88-121). This pep tide has previously been characterized as a competitive inhibitor for IL-6 binding to IL-6Ra (Ekida et aI., 1992) . Although IL-6 88-121 (2 /Lg/mL) displayed no toxicity in mixed cortical cultures, it prevented the neuroprotec tive effect of IL-6 against NMDA toxicity (10 /LmollL), as revealed by the increase in the LDH release in the bathing medium 24 hours after the application of the excitotoxin (Fig. 10 ) (n = 10; P < 0.0001).
DISCUSSION
In the present study, we investigated the implication of IL-6 during cerebral ischemia.
Our observation that the expression of the IL-6 gene is activated early in the injured cortex after focal cerebral ischemia is consistent with previous experimental data (Wang et aI., 1995; Hill et aI., 1999; Clark et aI., 1999) . Although we did not address the protein level, the well documented increase in IL-6 immunoreactivity (Maeda et aI., 1994; Saito et aI., 1996; Orzylowska et aI., 1999) and bioactivity (Loddick et aI., 1998) strongly supports the idea that the early occurrence of IL-6 mRNA pro duction (evidenced as early as 3 hours after occlusion) could influence the outcome of ischemic insults. Two major additional findings presented here are the follow ing: (1) the over-activation of NMDA receptors elicits an enhancement of IL-6 transcription in neurons; and 2) IL-6 exerts a neuroprotective effect restricted to NMDA induced excitotoxic necrosis.
Since the glutamatergic ionotropic receptor-mediated excitotoxic cascade is a major contributory factor for ischemic neuronal death (Choi, 1996) , we tested whether the activation of this pathway could reproduce the effect of cerebral ischemia on the expression of IL-6 mRNA. We evidenced that the injection of NMDA resulted in an enhancement of IL-6 transcription in the striatum similar to that provoked at the cortical level by MCAO. These observations suggest that the excitotoxic pathway could initiate the synthesis of IL-6 in the ischemic brain. This hypothesis is strengthened by the induction of IL-6 re ported after the striatal injection of another glutamatergic agonist, quinolinic acid (Schiefer et aI., 1998) . However, because increasing evidence suggests that NMDA may #Significantly different from NMDA+IL-6 by ANOVA, followed by Bonferronni-Dunn's test (P < 0.0001).
induce both excitotoxic and apoptotic mechanisms (Bon foco et aI., 1995) , and to eliminate any effect resulting from tissue lesion elicited by the striatal injection of NMDA, we developed an in vitro model allowing the investigation of the transcriptional modulation(s) medi ated during a severe glutamatergic ionotropic receptor mediated excitotoxic stress. In our conditions, the expo sure of pure cultured cortical neurons to high concentra tions of glutamatergic agonists, for up to 3 hours, induced the characteristic feature of necrosis (acute swelling of the cell body) without linkage of the neuronal membrane. We showed that cortical neurons are able to overexpress IL-6 mRNA in response to an intense NMDA receptor activation, an effect that is selectively blocked by MK-801. To investigate further the cellular signal(s) responsible for the increased transcription of IL-6, and because NMDA receptor activation is charac terized by a raise in the intracellular calcium concentra tion (MacDermott et aI., 1986), we tested the ability of a selective calcium ionophore, ionomycin (A23187) to mimic the activation of IL-6 mRNA expression induced by NMDA. In cultured cortical neurons, ionomycin elic ited a time-dependent activation of IL-6 transcription, similar to that resulting from NMDA exposure. Thus, the activation of IL-6 expression in neurons may involve a calcium-dependent pathway. Overall, these data demon strate that although glial cells have been suggested to be the source of IL-6 in the ischemic brain (Maeda et aI., 1994; Schiefer et aI., 1998) , neurons are a potential pa renchymal source of this cytokine. Recent evidence of IL-6 immunoreactive neurons in the ischemic rodent brain (Suzuki et aI., 1999a,b) supports that data. In ad dition, this is the first demonstration that the calcium ions influx evoked by the over-activation of NMDA receptors could be a critical signal for IL-6 production in the isch emic brain.
When considering the wide variety of central nervous system pathologies that exhibit a locally increased pro duction of IL-6, this cytokine may be viewed as a ubiq uitous alarm signal after tissue injury. However, the in fluence of this IL-6 induction remains controversial (Tarkowski et aI., 1995; Campbell, 1998; Qiu et aI., 1998; Toulmond et aI., 1992; Loddick et aI., 1998; Mat suda et aI., 1996) . To address the role of IL-6 during cerebral ischemia, we used cultured cortical neurons and astrocytes that express both the binding, (IL-6Ra) and the transducing (gp130) IL-6 receptors, and are thus able to respond to IL-6. These cultures were submitted to apoptotic and excitotoxic paradigms, reproducing the major pathways leading to ischemic neuronal death. By using two well characterized apoptotic challenges (serum deprivation and staurosporine exposure), we demon strated that recombinant IL-6 fails to prevent the neuro nal cell death, whereas cycloheximide succeeds. This observation can be related to the lack of protective effect J Cereb Blood Flow Metab. Vol. 20. No.6, 2000 of IL-6 against NO-induced cortical neuronal apoptotic cell death (Toku et aI., 1998) ; but contrasts with the beneficial activity of this cytokine against serum depri vation-mediated PC12 cell death (Umegaki et aI., 1996) . By using necrotic paradigms, we evidenced that IL-6 does not prevent AMPAlkainate receptor-mediated neu ronal death, but dose-dependently protects neurons against NMDA receptor-induced necrosis. We further characterized this selective protective activity of IL-6 by showing that it requires the binding of this cytokine to its receptor, because it is abolished by a competitive inhibi tor. Previous data have suggested that IL-6 could support neuronal survival by controlling the astrocytic activation (Fattori et aI., 1995; Raivich et aI., 1996) or secretion of neurotrophic factors (Kossmann et aI., 1996 , Marz et aI., 1999 , Carlson et aI., 1999 . Here we showed that astro cytes are not necessary for IL-6 neuroprotective activity, as evidenced by the maintenance of IL-6 beneficial effect against NMDA exposure in pure neuronal cultures. The idea that IL-6 directly targets neurons opens new insights into the cellular processes of IL-6-mediated neuroprotec tion during cerebral ischemia. However, further investi gations are required to extend our in vitro findings to the adult brain and to clarify the molecular mechanism(s) that underlies the protective effect of IL-6. In particular, the competitive inhibitor, which prevents the neuropro tective activity of IL-6 in cortical cultures, represents a powerful tool to evaluate the role of IL-6 during cerebral ischemia.
In summary, we demonstrate that during cerebral isch emia and other excitotoxicity-related injuries, neurons could synthesize and release IL-6 in response to the raise in the intracellular calcium concentration mediated through NMDA receptor activation, This induction of IL-6 could serve an endogenous autocrine protective mechanism, directly targeting neurons to prevent NMDA receptor-induced degeneration. These experimental ob servations, together with the clinical evidence of a cere bral production of IL-6 in stroke patients (Fassbender et aI., 1994 , Tarkowski et aI., 1995 , raise the possible rel evance of the IL-6 signaling pathway as an early target for the development of new therapeutic strategies.
